| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
Common |
| Shares
Out: |
76,320,000 |
| Market
Cap: |
6.41(M) |
| Last
Volume: |
222,317 |
Avg
Vol: |
221,713 |
| 52
Week Range: |
$0.1705 - $1.2 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Nymox Pharmaceutical is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of benign prostatic hyperplasia and the treatment of low-grade localized prostate cancer. Co. has developed and markets NicAlert™ and TobacAlert™, which are test strips for determining whether a person is using tobacco products (NicAlert™) or has been exposed to second-hand smoke (TobacAlert™). Both NicAlert™ and TobacAlert™ employ the patented technology of Co.'s subsidiary, Serex, Inc., to provide a read-out of levels of cotinine, a by-product of the body's breakdown of nicotine and generally regarded as the indicator of tobacco exposure for smokers and nonsmokers.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
80,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$36,800 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
2 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-14 |
2023-12-12 |
2023-06-13 |
2022-06-13 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Averback Paul |
CEO |
• • • |
2018-10-29 |
4 |
S |
$2.50 |
$4,219,000 |
D/D |
(1,687,600) |
21,643,948 |
|
- |
|
| Lanham Randall J |
General Counsel |
• • – |
2018-10-28 |
4 |
B |
$1.72 |
$4,988 |
D/D |
2,900 |
152,900 |
2.73 |
- |
|
| Averback Paul |
CEO |
• • • |
2018-10-26 |
4 |
S |
$1.75 |
$175,000 |
D/D |
(100,000) |
23,331,448 |
|
- |
|
| Robinson James George |
Director |
– • – |
2018-10-25 |
4 |
B |
$1.59 |
$16,225 |
D/D |
10,000 |
3,178,550 |
2.39 |
- |
|
| Robinson James George |
Director |
– • – |
2018-10-22 |
4 |
B |
$1.67 |
$13,340 |
D/D |
8,000 |
3,168,550 |
2.39 |
- |
|
| Robinson James George |
Director |
– • – |
2018-10-22 |
4 |
B |
$1.67 |
$13,340 |
D/D |
8,000 |
13,340 |
2.39 |
- |
|
| Robinson James George |
Director |
– • – |
2018-03-26 |
4 |
B |
$3.93 |
$31,434 |
D/D |
8,000 |
3,160,550 |
2.39 |
- |
|
| Robinson James George |
Director |
– • – |
2018-03-20 |
4 |
B |
$4.02 |
$32,160 |
D/D |
8,000 |
3,152,550 |
2.39 |
- |
|
| Robinson James George |
Director |
– • – |
2018-03-15 |
4 |
B |
$3.58 |
$28,672 |
D/D |
8,000 |
3,144,550 |
2.39 |
- |
|
| Robinson James George |
Director |
– • – |
2018-03-09 |
4 |
B |
$3.48 |
$27,864 |
D/D |
8,000 |
3,136,550 |
2.39 |
- |
|
| Robinson James George |
Director |
– • – |
2018-02-21 |
4 |
B |
$3.22 |
$19,373 |
D/D |
6,000 |
3,128,550 |
2.39 |
- |
|
| Robinson James George |
Director |
– • – |
2018-02-16 |
4 |
B |
$3.27 |
$22,921 |
D/D |
7,000 |
3,122,550 |
2.39 |
- |
|
| Robinson James George |
Director |
– • – |
2018-02-12 |
4 |
B |
$3.25 |
$26,161 |
D/D |
8,000 |
3,115,550 |
2.39 |
- |
|
| Robinson James George |
Director |
– • – |
2018-02-09 |
4 |
B |
$3.17 |
$22,254 |
D/D |
7,000 |
3,107,550 |
2.39 |
- |
|
| Robinson James George |
Director |
– • – |
2018-02-08 |
4 |
B |
$3.28 |
$33,717 |
D/D |
10,000 |
3,100,550 |
2.39 |
- |
|
| Robinson James George |
Director |
– • – |
2018-02-02 |
4 |
B |
$3.47 |
$17,350 |
D/D |
5,000 |
3,090,550 |
2.39 |
- |
|
| Robinson James George |
Director |
– • – |
2018-01-18 |
4 |
B |
$3.14 |
$9,415 |
D/D |
3,000 |
3,085,550 |
2.39 |
- |
|
| Robinson James George |
Director |
– • – |
2017-08-03 |
4 |
B |
$3.67 |
$18,350 |
D/D |
5,000 |
3,082,550 |
2.39 |
- |
|
| Robinson James George |
Director |
– • – |
2017-08-02 |
4 |
B |
$3.79 |
$18,950 |
D/D |
5,000 |
3,077,550 |
2.39 |
- |
|
| Robinson James George |
Director |
– • – |
2017-08-01 |
4 |
B |
$3.67 |
$18,350 |
D/D |
5,000 |
3,072,550 |
2.39 |
- |
|
| Robinson James George |
Director |
– • – |
2017-07-31 |
4 |
B |
$3.72 |
$18,600 |
D/D |
5,000 |
3,067,550 |
2.39 |
- |
|
| Robinson James George |
Director |
– • – |
2017-07-28 |
4 |
B |
$3.77 |
$18,850 |
D/D |
5,000 |
3,062,550 |
2.39 |
- |
|
| Robinson James George |
Director |
– • – |
2017-07-07 |
4 |
B |
$4.09 |
$14,415 |
D/D |
3,500 |
3,057,550 |
2.39 |
- |
|
| Robinson James George |
Director |
– • – |
2017-07-06 |
4 |
B |
$3.91 |
$11,770 |
D/D |
3,000 |
3,054,050 |
2.39 |
- |
|
| Robinson James George |
Director |
– • – |
2017-07-05 |
4 |
B |
$3.94 |
$19,845 |
D/D |
5,000 |
3,051,050 |
2.39 |
- |
|
164 Records found
|
|
Page 3 of 7 |
|
|
0.10 (53.33%) 
